Browse Research Content

This report evaluates environmental stressors to coral in the Florida Reef Tract with a focus on the Florida Keys through the lens of accepted global and local factors.

Nov 18, 2020

CHPA welcomes the opportunity to comment on the draft guidance on indications for nicotine replacement therapies (NRT).

Apr 12, 2019

Comments regarding guidance for clinical investigators, sponsors, and institutional review boards on investigational new drug applications - Determining whether human research studies can be conducted without an investigational new drug application.

Apr 7, 2014

This report builds upon current insights with findings from a new survey which examines two important stakeholder groups and analyzes what drives these groups’ use and trust in OTC medicines.

Mar 6, 2013

Enclosed herein are comments on "Guidance for Industry: Self-Selection Studies for Nonprescription Drug Products."

Nov 15, 2011

Letter regarding FDA draft guidance entitled “Investigational New Drug Applications (INDs) – Determining Whether Human Research Studies Can Be Conducted Without an Investigational New Drug Application.” These comments are focused on issues related to dietary supplements as referenced in the draft guidance.

Jan 11, 2011

CHPA comments on the “Notice of Availability of Draft Guidance Regarding Which Children’s Products are Subject to the Requirements of CPSIA Section 108.”

Mar 24, 2009

Filter Results